| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Oculis Holding AG
13G/A
Amendment 2
OCS · H5870P102
|
4.1% |
3/27/2026
Event 2/13/2026
|
|||
| BVCF IV, L.P. | 4.1% | ||||
| Beyeotech | 4.1% | ||||
| BVCF IV GP, Ltd. | 4.1% | ||||
| Zhi Yang | 4.1% | ||||
|
Oculis Holding AG
13G/A
Amendment 1
OCS · H5870P102
|
5.1% |
2/11/2025
Event 11/27/2024
|
|||
| BVCF IV, L.P. | 5.1% | ||||
| Beyeotech | 5.1% | ||||
| BVCF IV GP, Ltd. | 5.1% | ||||
| Zhi Yang | 5.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.